Page last updated: 2024-11-07

coriandrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Coriandrin is a natural coumarin compound isolated from the fruit of Coriandrum sativum (coriander). It has been shown to possess various biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. Coriandrin is known to inhibit the growth of certain bacteria and fungi. The compound is also being investigated for its potential therapeutic applications, such as in the treatment of cancer and Alzheimer's disease. Research on coriandrin focuses on understanding its mechanisms of action and exploring its potential as a drug candidate. The synthesis of coriandrin involves a series of chemical reactions, including the condensation of coumarin derivatives with appropriate precursors.'

coriandrin: from Coriandrum sativum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CoriandrumgenusA plant genus of the family APIACEAE. The leaves are the source of cilantro and the seeds are the source of coriander, both of which are used in SPICES.[MeSH]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]
Coriandrum sativumspecies[no description available]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID119586
CHEBI ID174178
MeSH IDM0174608

Synonyms (15)

Synonym
4-methoxy-7-methyluro[2,3-g]isochromen-5-one
CHEBI:174178
116408-80-1
coriandrin
4-methoxy-7-methylfuro[2,3-g]isochromen-5-one
ccris 8086
4-methoxy-7-methyl-5h-furo(2,3-g)benzopyran-5-one
5h-furo(2,3-g)(2)benzopyran-5-one, 4-methoxy-7-methyl-
DTXSID00151389
4-methoxy-7-methyl-5h-furo[2,3-g]isochromen-5-one
4-methoxy-7-methyl-5h-furo[2,3-g][2]benzopyran-5-one, 9ci
4-methoxy-7-methyl-5h-furo(2,3-g)(2)benzopyran-5-one
cariandrin
Q1132748
AKOS040736239
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isocoumarins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.39 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]